James M. Mock

Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer), Moderna, Inc.

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

James M. Mock signed the annual report of Moderna, Inc. as Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer); the report was filed on February 20, 2026, the most recent filing in the record that ties James M. Mock to the seat.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Moderna, Inc. (MRNA) Biological Products, (No Diagnostic Substances)	Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

February 20, 202610-K filed
James M. Mock signed the annual report of Moderna, Inc. on Form 10-K as Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer), filed February 20, 2026.
/s/ James M. Mock Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
[1] Annual report on Form 10-K by Moderna, Inc., filed with the SEC on February 20, 2026. Read the filing. The record at CFO Tribune.

Sources

Annual report on Form 10-K, Moderna, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed February 20, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or James M. Mock wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.